DR. RAVI ISHWAR THADHANI, MD
Osteopathic Medicine at Fruit St, Boston, MA
License number
Massachusetts 81439
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Massachusetts 81439
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
55 Fruit St, Boston, MA 02114
Phone
(617) 724-1207
(617) 726-2340 (Fax)
(617) 724-0287
(617) 726-2894 (Fax)
(617) 726-2340 (Fax)
(617) 724-0287
(617) 726-2894 (Fax)
Personal information
See more information about RAVI ISHWAR THADHANI at radaris.comName
Address
Phone
11 Byron St, Boston, MA 02108
6 Whittier Pl APT 11M, Boston, MA 02114
6 Whittier Pl APT 12M, Boston, MA 02114
Boston, MA
6 Whittier Pl, Boston, MA 02114
Professional information
Ravi Ishwar Thadhani, Boston MA
Specialties:
Internal Medicine, Nephrology
Work:
Massachusetts General Hospital
55 Fruit St, Boston, MA 02114
55 Fruit St, Boston, MA 02114
Education:
University of Pennsylvania(1991)
Dr. Ravi I Thadhani - MD (Doctor of Medicine)
Hospitals:
55 Fruit St, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
55 Fruit St, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
55 Fruit St, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
Education:
Medical Schools
University Of Pennsylvania School Of Medicine
Graduated: 1991
University Of Pennsylvania School Of Medicine
Graduated: 1991
Screening For Gestational Disorders
US Patent:
2008021, Sep 4, 2008
Filed:
Jan 9, 2008
Appl. No.:
11/971598
Inventors:
Ravi I. Thadhani - Boston MA, US
S. Ananth Karumanchi - Chestnut Hill MA, US
S. Ananth Karumanchi - Chestnut Hill MA, US
Assignee:
THE GENERAL HOSPITAL CORPORATION - Boston MA
BETH ISRAEL DEACONESS MEDICAL CENTER, INC. - Boston MA
BETH ISRAEL DEACONESS MEDICAL CENTER, INC. - Boston MA
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
The invention relates to methods and compositions for identifying subjects having, or predisposed to having, gestational diabetes, preeclampsia, and gestational hypertension. The methods are applicable to urine and/or blood samples and can be conducted prior to the third trimester of pregnancy.
Optimizing Erythropoietin Therapy
US Patent:
2012002, Jan 26, 2012
Filed:
Oct 16, 2009
Appl. No.:
13/123841
Inventors:
Ravi Thadhani - Boston MA, US
S. Ananth Karumanchi - Chestnut Hill MA, US
Eliyahu Khankin - Boston MA, US
Walter P. Mutter - West Newton MA, US
S. Ananth Karumanchi - Chestnut Hill MA, US
Eliyahu Khankin - Boston MA, US
Walter P. Mutter - West Newton MA, US
Assignee:
BETH ISRAEL DEACONESS MEDICAL CENTER, INC. - Boston MA
THE GENERAL HOSPITAL CORPORATION - Boston MA
THE GENERAL HOSPITAL CORPORATION - Boston MA
International Classification:
A61K 39/395, A61P 3/00, A61K 38/18, G01N 33/566, C12Q 3/00
US Classification:
4241391, 435 792, 436501, 435 71, 435 3, 514 77
Abstract:
The methods described herein can be used to identify ex ante which hemodialysis patients are likely to develop EPO resistance and therefore will require additional rHu EPO, and to provide treatments that can reduce the need for additional rHu EPO. In addition, the methods can be used to predict which subjects have a higher risk of mortality, to identify high-risk patients who can then be monitored more closely or treated more aggressively. Also provided are kits for carrying out the described methods.
Screening For Gestational Disorders
US Patent:
7344892, Mar 18, 2008
Filed:
Sep 23, 2004
Appl. No.:
10/947791
Inventors:
Ravi I. Thadhani - Boston MA, US
S. Ananth Karumanchi - Chestnut Hill MA, US
S. Ananth Karumanchi - Chestnut Hill MA, US
Assignee:
Beth Israel Deaconess Medical Center, Inc. - Boston MA
The General Hospital Corporation - Boston MA
The General Hospital Corporation - Boston MA
International Classification:
G01N 33/53, G01N 33/577
US Classification:
436501, 436804, 436809, 435 71
Abstract:
The invention relates to methods and compositions for identifying subjects having, or predisposed to having, gestational diabetes, preeclampsia, and gestational hypertension. The methods are applicable to urine and/or blood samples and can be conducted prior to the third trimester of pregnancy.
Screening For Gestational Disorders
US Patent:
2005014, Jul 7, 2005
Filed:
Aug 16, 2004
Appl. No.:
10/920116
Inventors:
Ravi Thadhani - Boston MA, US
Myles Wolf - Brookline MA, US
Tanya Knickerbocker - Brighton MA, US
Gavin MacBeath - Arlington MA, US
Myles Wolf - Brookline MA, US
Tanya Knickerbocker - Brighton MA, US
Gavin MacBeath - Arlington MA, US
International Classification:
G01N033/53
US Classification:
435007100
Abstract:
The invention relates to methods and compositions for identifying pregnant subjects having, or predisposed to having, gestational diabetes, preeclampsia, and gestational hypertension. The methods are applicable to urine and/or blood samples and can be conducted prior to the third trimester of pregnancy, and as early as the first trimester.
Diagnostic And Therapeutic Uses Of Gelsolin In Renal Failure
US Patent:
2009025, Oct 15, 2009
Filed:
Jan 23, 2009
Appl. No.:
12/358868
Inventors:
Ravi Thadhani - Boston MA, US
Thomas P. Stossel - Belmont MA, US
Po-Shun Lee - Brookline MA, US
Ananth Karumanchi - Chestnut Hill MA, US
Thomas P. Stossel - Belmont MA, US
Po-Shun Lee - Brookline MA, US
Ananth Karumanchi - Chestnut Hill MA, US
International Classification:
A61K 38/16, G01N 33/68, A61P 13/12
US Classification:
514 12, 436 86
Abstract:
The invention is directed, in part, to the use of gelsolin to diagnose, monitor, and treat subjects with renal failure (e.g., chronic renal failure subjects on dialysis).
Predicting Diabetic Nephropathy
US Patent:
2007011, May 17, 2007
Filed:
Nov 9, 2006
Appl. No.:
11/595562
Inventors:
Ravi Thadhani - Boston MA, US
S. Karumanchi - Chestnut Hill MA, US
Towia Libermann - Chestnut Hil MA, US
S. Karumanchi - Chestnut Hill MA, US
Towia Libermann - Chestnut Hil MA, US
International Classification:
C12Q 1/68, G01N 33/53, C12M 3/00
US Classification:
435006000, 435007100, 435287200
Abstract:
The invention relates to methods and compositions for identifying subjects who are predisposed to having diabetic nephropathy (DN).
Predicting Diabetic Nephropathy
US Patent:
2008011, May 15, 2008
Filed:
Jan 24, 2008
Appl. No.:
12/018945
Inventors:
Ravi Thadhani - Boston MA, US
S. Karumanchi - Chestnut Hill MA, US
Towia Libermann - Chestnut Hill MA, US
S. Karumanchi - Chestnut Hill MA, US
Towia Libermann - Chestnut Hill MA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
G01N 33/53
US Classification:
435007100, 436086000
Abstract:
The invention relates to methods and compositions for identifying subjects who are predisposed to having diabetic nephropathy (DN).